BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38568469)

  • 1. Diagnostic Approaches to Investigate JAK2-Unmutated Erythrocytosis Based on a Single Tertiary Center Experience.
    Lee Y; Seo SH; Kim J; Kim SA; Lee JY; Lee JO; Bang SM; Park KU; Hwang SM
    Mol Diagn Ther; 2024 May; 28(3):311-318. PubMed ID: 38568469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational Landscape of Patients Referred for Elevated Hemoglobin Level.
    Bhai P; Chin-Yee B; Pope V; Cheong I; Matyashin M; Levy MA; Foroutan A; Stuart A; Hsia CC; Lin H; Sadikovic B; Chin-Yee I
    Curr Oncol; 2022 Sep; 29(10):7209-7217. PubMed ID: 36290845
    [No Abstract]   [Full Text] [Related]  

  • 3. JAK2 unmutated erythrocytosis: 2023 Update on diagnosis and management.
    Gangat N; Szuber N; Tefferi A
    Am J Hematol; 2023 Jun; 98(6):965-981. PubMed ID: 36966432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JAK2 unmutated erythrocytosis: current diagnostic approach and therapeutic views.
    Gangat N; Szuber N; Pardanani A; Tefferi A
    Leukemia; 2021 Aug; 35(8):2166-2181. PubMed ID: 34021251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline JAK2 E846D Substitution as the Cause of Erythrocytosis?
    Maaziz N; Garrec C; Airaud F; Bobée V; Contentin N; Cayssials E; Rimbert A; Aral B; Bézieau S; Gardie B; Girodon F
    Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular study of congenital erythrocytosis in 70 unrelated patients revealed a potential causal mutation in less than half of the cases (Where is/are the missing gene(s)?).
    Bento C; Almeida H; Maia TM; Relvas L; Oliveira AC; Rossi C; Girodon F; Fernandez-Lago C; Aguado-Diaz A; Fraga C; Costa RM; Araújo AL; Silva J; Vitória H; Miguel N; Silveira MP; Martin-Nuñez G; Ribeiro ML
    Eur J Haematol; 2013 Oct; 91(4):361-8. PubMed ID: 23859443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations.
    Camps C; Petousi N; Bento C; Cario H; Copley RR; McMullin MF; van Wijk R; Ratcliffe PJ; Robbins PA; Taylor JC;
    Haematologica; 2016 Nov; 101(11):1306-1318. PubMed ID: 27651169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole Exome Sequencing Reveals Novel Variants in Unexplained Erythrocytosis.
    Khurana H; Muthusamy B; Yanamandra U; Garapati K; Premdeep H; Subramanian S; Pandey A
    OMICS; 2023 Jul; 27(7):299-304. PubMed ID: 37428608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Variants Associated With Rare Hematological Disorder Erythrocytosis Using Targeted Next-Generation Sequencing Analysis.
    Kristan A; Pajič T; Maver A; Režen T; Kunej T; Količ R; Vuga A; Fink M; Žula Š; Podgornik H; Anžej Doma S; Preložnik Zupan I; Rozman D; Debeljak N
    Front Genet; 2021; 12():689868. PubMed ID: 34349782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NGS Evaluation of a Bernese Cohort of Unexplained Erythrocytosis Patients.
    Jalowiec KA; Vrotniakaite-Bajerciene K; Capraru A; Wojtovicova T; Joncourt R; Rovó A; Porret NA
    Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Performance of Erythropoietin Levels in Polycythemia Vera: Experience at a Comprehensive Cancer Center.
    Davila-Gonzalez D; Barrios-Ruiz A; Fountain E; Cheng L; Masarova L; Verstovsek S; Rojas-Hernandez CM
    Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):224-229. PubMed ID: 33349602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic variations and new mutations in JAK2 V617F-negative polycythemia vera, erythrocytosis, and idiopathic myelofibrosis.
    Williams DM; Kim AH; Rogers O; Spivak JL; Moliterno AR
    Exp Hematol; 2007 Nov; 35(11):1641-6. PubMed ID: 17920755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperation of germ line JAK2 mutations E846D and R1063H in hereditary erythrocytosis with megakaryocytic atypia.
    Kapralova K; Horvathova M; Pecquet C; Fialova Kucerova J; Pospisilova D; Leroy E; Kralova B; Milosevic Feenstra JD; Schischlik F; Kralovics R; Constantinescu SN; Divoky V
    Blood; 2016 Sep; 128(10):1418-23. PubMed ID: 27389715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic erythrocytosis: a germline disease?
    Elli EM; Mauri M; D'Aliberti D; Crespiatico I; Fontana D; Redaelli S; Pelucchi S; Spinelli S; Manghisi B; Cavalca F; Aroldi A; Ripamonti A; Ferrari S; Palamini S; Mottadelli F; Massimino L; Ramazzotti D; Cazzaniga G; Piperno A; Gambacorti-Passerini C; Piazza R
    Clin Exp Med; 2024 Jan; 24(1):11. PubMed ID: 38244120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two Novel Genetic Variants Involved in the Oxygen Sensing Pathway in JAK2-unmutated Erythrocytosis.
    Ma Q; Hu R; Hui W; Zhao H; Zou D; Liu Y; Sun W
    Biochem Genet; 2024 Apr; ():. PubMed ID: 38568374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of JAK2 unmutated erythrocytosis: Distinctive traits between polycythemia vera and non-polycythemia vera patients.
    Ernest V; Abbou N; Tichadou A; Arcani R; Venton G
    Eur J Intern Med; 2023 Jan; 107():113-115. PubMed ID: 36096924
    [No Abstract]   [Full Text] [Related]  

  • 17. Algorithmic evaluation of hereditary erythrocytosis: Pathways and caveats.
    Oliveira JL
    Int J Lab Hematol; 2019 May; 41 Suppl 1():89-94. PubMed ID: 31069987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocytosis: genes and pathways involved in disease development.
    Gašperšič J; Kristan A; Kunej T; Zupan IP; Debeljak N
    Blood Transfus; 2021 Nov; 19(6):518-532. PubMed ID: 33370224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera.
    Schnittger S; Bacher U; Haferlach C; Geer T; Müller P; Mittermüller J; Petrides P; Schlag R; Sandner R; Selbach J; Slawik HR; Tessen HW; Wehmeyer J; Kern W; Haferlach T
    Haematologica; 2009 Mar; 94(3):414-8. PubMed ID: 19252176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the variant allele frequency of ASXL1, DNMT3A, JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia.
    Sasaki K; Kanagal-Shamanna R; Montalban-Bravo G; Assi R; Jabbour E; Ravandi F; Kadia T; Pierce S; Takahashi K; Nogueras Gonzalez G; Patel K; Soltysiak KA; Cortes J; Kantarjian HM; Garcia-Manero G
    Cancer; 2020 Feb; 126(4):765-774. PubMed ID: 31742675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.